Literature DB >> 17132029

To retain or remove user fees?: reflections on the current debate in low- and middle-income countries.

Chris D James1, Kara Hanson, Barbara McPake, Dina Balabanova, Davidson Gwatkin, Ian Hopwood, Christina Kirunga, Rudolph Knippenberg, Bruno Meessen, Saul S Morris, Alexander Preker, Yves Souteyrand, Abdelmajid Tibouti, Pascal Villeneuve, Ke Xu.   

Abstract

Many low- and middle-income countries continue to search for better ways of financing their health systems. Common to many of these systems are problems of inadequate resource mobilisation, as well as inefficient and inequitable use of existing resources. The poor and other vulnerable groups who need healthcare the most are also the most affected by these shortcomings. In particular, these groups have a high reliance on user fees and other out-of-pocket expenditures on health which are both impoverishing and provide a financial barrier to care. It is within this context, and in light of recent policy initiatives on user fee removal, that a debate on the role of user fees in health financing systems has recently returned. This paper provides some reflections on the recent user fees debate, drawing from the evidence presented and subsequent discussions at a recent UNICEF consultation on user fees in the health sector, and relates the debate to the wider issue of access to adequate healthcare. It is argued that, from the wealth of evidence on user fees and other health system reforms, a broad consensus is emerging. First, user fees are an important barrier to accessing health services, especially for poor people. They also negatively impact on adherence to long-term expensive treatments. However, this is offset to some extent by potentially positive impacts on quality. Secondly, user fees are not the only barrier that the poor face. As well as other cost barriers, a number of quality, information and cultural barriers must also be overcome before the poor can access adequate health services. Thirdly, initial evidence on fee abolition in Uganda suggests that this policy has improved access to outpatient services for the poor. For this to be sustainable and effective in reaching the poor, fee removal needs to be part of a broader package of reforms that includes increased budgets to offset lost fee revenue (as was the case in Uganda). Fourthly, implementation matters: if fees are to be abolished, this needs clear communication with a broad stakeholder buy-in, careful monitoring to ensure that official fees are not replaced by informal fees, and appropriate management of the alternative financing mechanisms that are replacing user fees. Fifthly, context is crucial. For instance, immediate fee removal in Cambodia would be inappropriate, given that fees replaced irregular and often high informal fees. In this context, equity funds and eventual expansion of health insurance are perhaps more viable policy options. Conversely, in countries where user fees have had significant adverse effects on access and generated only limited benefits, fee abolition is probably a more attractive policy option. Removing user fees has the potential to improve access to health services, especially for the poor, but it is not appropriate in all contexts. Analysis should move on from broad evaluations of user fees towards exploring how best to dismantle the multiple barriers to access in specific contexts.

Entities:  

Mesh:

Year:  2006        PMID: 17132029     DOI: 10.2165/00148365-200605030-00001

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  70 in total

1.  Analyzing the influence of institutions on health policy development in Uganda: a case study of the decision to abolish user fees.

Authors:  K A Moat; J Abelson
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

Review 2.  The impact of user fees on health service utilization in low- and middle-income countries: how strong is the evidence?

Authors:  Mylene Lagarde; Natasha Palmer
Journal:  Bull World Health Organ       Date:  2008-11       Impact factor: 9.408

3.  The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.

Authors:  Arnousse Beaulière; Siaka Touré; Pierre-Kébreau Alexandre; Koko Koné; Alex Pouhé; Bertin Kouadio; Neige Journy; Jérôme Son; Virginie Ettiègne-Traoré; François Dabis; Serge Eholié; Xavier Anglaret
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

4.  The implications of policy changes on the uptake of a PMTCT programme in rural Malawi: first three years of experience.

Authors:  Fyson Kasenga; Peter Byass; Maria Emmelin; Anna-Karin Hurtig
Journal:  Glob Health Action       Date:  2009-01-23       Impact factor: 2.640

Review 5.  Global report on preterm birth and stillbirth (4 of 7): delivery of interventions.

Authors:  Cesar G Victora; Craig E Rubens
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

6.  Direct facility funding as a response to user fee reduction: implementation and perceived impact among Kenyan health centres and dispensaries.

Authors:  Antony Opwora; Margaret Kabare; Sassy Molyneux; Catherine Goodman
Journal:  Health Policy Plan       Date:  2010-03-08       Impact factor: 3.344

7.  Cost and disease burden of dengue in Cambodia.

Authors:  Julien Beauté; Sirenda Vong
Journal:  BMC Public Health       Date:  2010-08-31       Impact factor: 3.295

8.  Low coverage but few inclusion errors in Burkina Faso: a community-based targeting approach to exempt the indigent from user fees.

Authors:  Valéry Ridde; Slim Haddad; Béatrice Nikiema; Moctar Ouedraogo; Yamba Kafando; Abel Bicaba
Journal:  BMC Public Health       Date:  2010-10-21       Impact factor: 3.295

9.  Abolishing user fees in Africa.

Authors:  Valéry Ridde; Slim Haddad
Journal:  PLoS Med       Date:  2009-01-06       Impact factor: 11.069

10.  Financial access to health care in Karuzi, Burundi: a household-survey based performance evaluation.

Authors:  Sophie Lambert-Evans; Frederique Ponsar; Tony Reid; Catherine Bachy; Michel Van Herp; Mit Philips
Journal:  Int J Equity Health       Date:  2009-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.